Sector News

Categories

Borderless Insights

Image
The Skills-Forward Revolution:   Stretching the Boundaries of Professional Flexibility
Image
Sustainability: Business Leaders Must Secure the Long-Term Strategy Despite Short-Term Pressures
Image
Negotiating Terms with a New Employer

Drugmaker GSK to steer Asian business from new Singapore HQ

March 11, 2015
Life sciences
(Reuters) – Drugmaker GlaxoSmithKline will establish a new headquarters for Asia in Singapore to make quicker decisions for the region, a move that follows a recent rocky ride in China due to a damaging bribery scandal.
 
The British-based group said it expects its pharmaceutical, consumer healthcare and vaccine businesses to grow significantly faster in Asia than in the rest of the world.
 
“While we expect it to be a bit slower going forward than it was five years ago, we still think it’s going to be a very vibrant growth area,” Chief Executive Andrew Witty told reporters.
 
Witty has made emerging markets a priority for GSK since taking over in 2008.
 
GSK has over 700 office-based employees in Singapore and expects an additional 100 roles to move into the country as the headquarters nears completion. Construction is expected to be finished by the end of 2016.
 
Asia business decisions are currently mainly handled out of London.
 
Last year, the drugmaker was fined 3 billion yuan ($479 million) in China following allegations in 2013 it funnelled funds to travel agencies to facilitate bribes to doctors and officials. The high-profile case hit GSK’s drug sales in the country.
 
It is dismissing 110 employees in China for misconduct, people familiar with the matter said this month.
 
“I don’t have an expectation that there will be more people leaving, but equally if we found somebody else who did something wrong then they would go through the process and whatever would happen would happen,” Witty said.
 
GSK’s move follows similar ones by other global companies, including automaker General Motors Co, which moved its international operations headquarters to the city-state last year.
 
Companies are lured to Singapore by its competitive tax rates, use of the English language, skilled workforce and high standards of living. (Reporting by Aradhana Aravindan and Ben Hirschler; Editing by Tom Heneghan and Edwina Gibbs)

comments closed

Related News

July 21, 2024

CordenPharma invests €900m in peptide platform expansion

Life sciences

CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform. The planned investment consists of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions.

Read more
July 21, 2024

DSM-Firmenich to sell MEG-3 fish oil business to KD Pharma Group

Life sciences

DSM-Firmenich has announced the sale of its MEG-3 fish oil business to KD Pharma Group, a contract development and manufacturing organisation that is active in pharmaceutical and nutritional lipids. As part of the transaction, DSM-Firmenich will obtain a minority stake of 29% in KD Pharma’s parent company O³ Holding GmbH.

Read more
July 21, 2024

Veranova appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer

Life sciences

Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutica l and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer. Cécile will join the executive team and assume responsibility for business development, marketing, project management, commercial operations, and product management.

Read more
More news

How can we help you?

We're easy to reach